| Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation | New England Journal of Medicine | 2017 | 1.1K |
| Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343 | Journal of Clinical Oncology | 2013 | 695 |
| Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial | Journal of Clinical Oncology | 2017 | 434 |
| BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes | Journal of Clinical Oncology | 2002 | 417 |
| Designs for group sequential tests | Contemporary Clinical Trials | 1984 | 281 |
| Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma | Autophagy | 2014 | 252 |
| Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib | Journal of Clinical Oncology | 2016 | 242 |
| Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 233 |
| Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance) | Journal of Clinical Oncology | 2015 | 157 |
| Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial | Annals of Surgery | 2013 | 125 |
| Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies | Annals of Internal Medicine | 2015 | 122 |
| Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502 | Journal of Clinical Oncology | 2015 | 111 |
| A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer | American Journal of Clinical Nutrition | 2009 | 108 |
| Aspirin and COX-2 inhibitor use in patients with stage III colon cancer | Journal of the National Cancer Institute | 2015 | 101 |
| Discrimination of non-protein-coding transcripts from protein-coding mRNA | RNA Biology | 2006 | 90 |
| Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy | Annals of Surgery | 2003 | 85 |
| Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study | Journal of Clinical Oncology | 2006 | 84 |
| Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance) | Journal of Clinical Oncology | 2014 | 66 |
| A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation | Blood | 2003 | 66 |
| Randomized trial of a physical activity intervention in women with metastatic breast cancer | Cancer | 2016 | 63 |
| CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers | Journal of Clinical Oncology | 2016 | 62 |
| PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance) | Npj Breast Cancer | 2016 | 58 |
| Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group | Pediatric Blood and Cancer | 2012 | 57 |
| Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design | Npj Breast Cancer | 2017 | 54 |
| Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance) | Journal of Oncology Practice | 2014 | 45 |
